These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1626 related articles for article (PubMed ID: 28969548)

  • 1. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
    Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
    J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer.
    Truffi M; Fiandra L; Sorrentino L; Monieri M; Corsi F; Mazzucchelli S
    Pharmacol Res; 2016 May; 107():57-65. PubMed ID: 26968122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress in 808 nm Excited Upconversion Nanomaterials as Multifunctional Nanoprobes for Visualized Theranostics in Cancers.
    Zeng L; Wu D; Tian Y; Pan Y; Wu A; Zhang J; Lu G
    Curr Med Chem; 2018; 25(25):2954-2969. PubMed ID: 28322153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical Applications of Nanomaterials as Therapeutics.
    Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
    Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
    Gupta N; Rai DB; Jangid AK; Kulhari H
    Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    Chen D; Dougherty CA; Zhu K; Hong H
    J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanide-doped hollow nanomaterials as theranostic agents.
    Kang X; Li C; Cheng Z; Ma P; Hou Z; Lin J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(1):80-101. PubMed ID: 24227795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.